Volume 24, Issue 6 (Iranian South Medical Journal 2021)
Iran South Med J 2021, 24(6): 637-638 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Abbasi M. Hypothesis Generation: Does Lu177 Therapy May be Effective for Treatment of Benign Prostate Hyperthrophy?. Iran South Med J 2021; 24 (6) :637-638
URL: http://ismj.bpums.ac.ir/article-1-1558-en.html
URL: http://ismj.bpums.ac.ir/article-1-1558-en.html
Department of Nuclear Medicine, Tehran University of Medical Sciences , meabbasi@tums.ac.ir
Abstract: (675 Views)
It has been decades full of documents to support the effectiveness and safety of I131 therapy for benign and malignant thyroid disease. Benign hyperfunctioning thyroid nodules and post thyroidectomy malignant metastases accumulate I131. Recently Lu177 PSMA has been successfully used for the treatment of prostate cancer metastases. Comparing the thyroid and prostate may bring a theory to treat benign prostate hypertrophy with Lu177 PSMA. Although proceeding to practice needs prior dosimetry study, effectiveness and safety evaluation, and cost-benefits assessment, the idea on its own is interesting.
Type of Study: Letter to Editor |
Subject:
Radiology. Diagnostic Imaging
Received: 2022/03/6 | Accepted: 2022/03/16 | Published: 2022/05/7
Received: 2022/03/6 | Accepted: 2022/03/16 | Published: 2022/05/7
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
